PE74699A1 - Utilizacion de las heparinas de bajo peso molecular para la prevencion y el tratamiento del trauma del sistema nervioso central - Google Patents
Utilizacion de las heparinas de bajo peso molecular para la prevencion y el tratamiento del trauma del sistema nervioso centralInfo
- Publication number
- PE74699A1 PE74699A1 PE1998000386A PE00038698A PE74699A1 PE 74699 A1 PE74699 A1 PE 74699A1 PE 1998000386 A PE1998000386 A PE 1998000386A PE 00038698 A PE00038698 A PE 00038698A PE 74699 A1 PE74699 A1 PE 74699A1
- Authority
- PE
- Peru
- Prior art keywords
- molecular weight
- low molecular
- heparines
- trauma
- prevention
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/727—Heparin; Heparan
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Dermatology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Abstract
SE REFIERE A HEPARINAS DE BAJO PESO MOLECULAR COMPRENDIDO ENTRE 1000 Y 10000 DALTONS EN PARTICULAR ENTRE 4000 Y 5000 DALTONS. LA HEPARINA ESTA CONSTITUIDA POR OLIGOSACARIDOS QUE TIENEN UN ACIDO 2-O-SULFO-4-ENOPIRANOSURONICO EN UNO DE SUS EXTREMOS. SE OBTIENE LA HEPARINA POR DESPOLIMERIZADO DE UN ESTER DE HEPARINA POR MEDIO DE UNA BASE COMO LA SOSA. LA HEPARINA DE BAJO PESO MOLECULAR ES LA ENOXAPARINA, NADROPARINA, PARNAPARINA, REVIPARINA, ENTRE OTRAS; LAS QUE PUEDEN SER UTILES PARA LA PREVENCION Y EL TRATAMIENTO DEL TRAUMA DEL SISTEMA NERVIOSO CENTRAL, PRINCIPALMENTE DEL TRAUMATISMO ESPINAL, CRANEAL O CRANEO-ESPINAL
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9706550A FR2763848B1 (fr) | 1997-05-28 | 1997-05-28 | Utilisation des heparines de bas poids moleculaire pour la prevention et le traitement du trauma du systeme nerveux central |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE74699A1 true PE74699A1 (es) | 1999-10-21 |
Family
ID=9507335
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE1998000386A PE74699A1 (es) | 1997-05-28 | 1998-05-19 | Utilizacion de las heparinas de bajo peso molecular para la prevencion y el tratamiento del trauma del sistema nervioso central |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US6380173B1 (es) |
| EP (2) | EP0984786B1 (es) |
| JP (1) | JP2002500660A (es) |
| KR (1) | KR100531721B1 (es) |
| CN (1) | CN1212845C (es) |
| AR (1) | AR012876A1 (es) |
| AT (1) | ATE276752T1 (es) |
| AU (1) | AU752322B2 (es) |
| BR (1) | BR9809504A (es) |
| CA (1) | CA2290675A1 (es) |
| DE (1) | DE69826460T2 (es) |
| ES (1) | ES2227841T3 (es) |
| FR (1) | FR2763848B1 (es) |
| IL (2) | IL132671A0 (es) |
| MA (1) | MA24553A1 (es) |
| NO (1) | NO317517B1 (es) |
| NZ (1) | NZ501365A (es) |
| PE (1) | PE74699A1 (es) |
| PT (1) | PT984786E (es) |
| RU (1) | RU2215531C2 (es) |
| TN (1) | TNSN98071A1 (es) |
| TW (1) | TW533075B (es) |
| WO (1) | WO1998053833A1 (es) |
| ZA (1) | ZA984432B (es) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20010041686A1 (en) * | 2000-01-06 | 2001-11-15 | Veronique Mary | Novel therapeutic application of enoxaparin |
| US9308220B2 (en) | 2001-12-11 | 2016-04-12 | Cosmo Technologies Limited | Pharmaceutical compositions for the oral administration of heparin or derivatives thereof |
| ITMI20012599A1 (it) * | 2001-12-11 | 2003-06-11 | Cosmo Spa | Composizioni farmaceutiche per la somministrazione orale di eparina osuoi derivati, utili per la terapia di malattie infiammatorie dell'int |
| US7511026B2 (en) | 2003-03-25 | 2009-03-31 | Seikagaku Corporation | Therapeutic agent for nerve damage |
| ITMI20031023A1 (it) * | 2003-05-21 | 2004-11-22 | Umberto Cornelli | Glicosaminoglicani aventi peso molecolare medio 2400 d atti al trattamento delle disfunzioni emozionali. |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA829463B (en) * | 1982-07-19 | 1983-10-26 | Hepar Ind Inc | Process for manufacturing low molecular weight heparins by depolymerization of normal heparin |
| FR2614026B1 (fr) * | 1987-04-16 | 1992-04-17 | Sanofi Sa | Heparines de bas poids moleculaire, a structure reguliere, leur preparation et leurs applications biologiques |
| IT1243300B (it) * | 1990-12-20 | 1994-05-26 | Fidia Spa | Derivati dell'eparina |
| IT1264530B (it) * | 1992-07-31 | 1996-10-02 | Crinos Industria Farmaco | Impiego dei polisaccaridi nelle neuropatie atrofico degenerative |
-
1997
- 1997-05-28 FR FR9706550A patent/FR2763848B1/fr not_active Expired - Fee Related
-
1998
- 1998-05-19 PE PE1998000386A patent/PE74699A1/es not_active Application Discontinuation
- 1998-05-25 CN CNB988054892A patent/CN1212845C/zh not_active Expired - Fee Related
- 1998-05-25 WO PCT/FR1998/001034 patent/WO1998053833A1/fr active IP Right Grant
- 1998-05-25 EP EP98925773A patent/EP0984786B1/fr not_active Expired - Lifetime
- 1998-05-25 DE DE69826460T patent/DE69826460T2/de not_active Expired - Lifetime
- 1998-05-25 BR BR9809504-8A patent/BR9809504A/pt not_active Application Discontinuation
- 1998-05-25 KR KR10-1999-7010960A patent/KR100531721B1/ko not_active IP Right Cessation
- 1998-05-25 MA MA25088A patent/MA24553A1/fr unknown
- 1998-05-25 JP JP50031099A patent/JP2002500660A/ja not_active Ceased
- 1998-05-25 RU RU99128105/14A patent/RU2215531C2/ru not_active IP Right Cessation
- 1998-05-25 TW TW087108065A patent/TW533075B/zh not_active IP Right Cessation
- 1998-05-25 AU AU77759/98A patent/AU752322B2/en not_active Ceased
- 1998-05-25 EP EP04003133A patent/EP1421943A1/fr not_active Withdrawn
- 1998-05-25 IL IL13267198A patent/IL132671A0/xx active IP Right Grant
- 1998-05-25 AT AT98925773T patent/ATE276752T1/de not_active IP Right Cessation
- 1998-05-25 ZA ZA984432A patent/ZA984432B/xx unknown
- 1998-05-25 ES ES98925773T patent/ES2227841T3/es not_active Expired - Lifetime
- 1998-05-25 PT PT98925773T patent/PT984786E/pt unknown
- 1998-05-25 NZ NZ501365A patent/NZ501365A/xx unknown
- 1998-05-25 CA CA002290675A patent/CA2290675A1/fr not_active Abandoned
- 1998-05-27 AR ARP980102470A patent/AR012876A1/es unknown
- 1998-05-27 TN TNTNSN98071A patent/TNSN98071A1/fr unknown
-
1999
- 1999-11-01 IL IL132671A patent/IL132671A/en not_active IP Right Cessation
- 1999-11-12 NO NO19995538A patent/NO317517B1/no not_active IP Right Cessation
- 1999-11-24 US US09/448,244 patent/US6380173B1/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| WO1998053833A1 (fr) | 1998-12-03 |
| TNSN98071A1 (fr) | 2005-03-15 |
| MA24553A1 (fr) | 1998-12-31 |
| NO995538L (no) | 1999-11-12 |
| BR9809504A (pt) | 2000-06-20 |
| NO317517B1 (no) | 2004-11-08 |
| AU7775998A (en) | 1998-12-30 |
| RU2215531C2 (ru) | 2003-11-10 |
| ZA984432B (en) | 1998-12-02 |
| EP0984786B1 (fr) | 2004-09-22 |
| NO995538D0 (no) | 1999-11-12 |
| IL132671A0 (en) | 2001-03-19 |
| CN1257428A (zh) | 2000-06-21 |
| DE69826460T2 (de) | 2005-10-13 |
| IL132671A (en) | 2007-06-17 |
| KR20010012988A (ko) | 2001-02-26 |
| JP2002500660A (ja) | 2002-01-08 |
| AR012876A1 (es) | 2000-11-22 |
| FR2763848A1 (fr) | 1998-12-04 |
| DE69826460D1 (de) | 2004-10-28 |
| AU752322B2 (en) | 2002-09-19 |
| ATE276752T1 (de) | 2004-10-15 |
| NZ501365A (en) | 2002-12-20 |
| KR100531721B1 (ko) | 2005-11-28 |
| EP0984786A1 (fr) | 2000-03-15 |
| EP1421943A1 (fr) | 2004-05-26 |
| PT984786E (pt) | 2005-01-31 |
| TW533075B (en) | 2003-05-21 |
| FR2763848B1 (fr) | 2000-01-28 |
| US6380173B1 (en) | 2002-04-30 |
| CA2290675A1 (fr) | 1998-12-03 |
| CN1212845C (zh) | 2005-08-03 |
| ES2227841T3 (es) | 2005-04-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5091171B2 (en) | Amphoteric compositions and polymeric forms of alpha hydroxyacids and their therapeutic use | |
| KR890011918A (ko) | 개선된 의료용 폴리(프로필렌 글리콜 푸마레이트)조성물 | |
| BR9809792A (pt) | Polìmeros enxertados enrijecidos | |
| ES2160397T3 (es) | Composicion filmogena densa. | |
| ES2130268T3 (es) | Preparados de acido hialuronico de bajo peso molecular, para estimulacion de formacion de huesos. | |
| BR9612032A (pt) | Polìmero em blocos linear compreendendo grupos uréia e uretano, método para a produção de polìmeros em blocos lineares e uso dos polìmeros em blocos como implantes. | |
| MX167917B (es) | Nuevos materiales y dispositivos quirurgicos | |
| IT1306679B1 (it) | Uso dei derivati dell'acido ialuronico per la preparazione dicomposizoni farmaceutiche e biomateriali per la prevenzione della | |
| BR0116096A (pt) | Composto, composição farmacêutica, e, métodos para tratar uma condição ou doença inflamatória ou imune em um paciente, para tratar uma condição ou doença mediada por cxcr3 em um paciente, e para a modulação da função de cxcr3 em uma célula | |
| ITPD910229A1 (it) | Tessuto non tessuto essenzialmente costituito da derivati dell'acido ialuronico | |
| ATE196093T1 (de) | Fibrin oder fibrinogen sowie biologisch abbaubare und biokompatible polymere enthaltende zusammensetzung zur gewebebehandlung | |
| AR008378A1 (es) | Conjudados de interferon | |
| HK1106161A1 (en) | Amide derivatives of hyaluronic acid in osteoarthrosis | |
| AR009089A1 (es) | Composiciones para el cuidado del color que comprenden un agente fijador de colorante y un polimero y un metodo para proporcionar cuidado de color | |
| PE74699A1 (es) | Utilizacion de las heparinas de bajo peso molecular para la prevencion y el tratamiento del trauma del sistema nervioso central | |
| ES2066152T3 (es) | Composiciones que contienen derivados de la quitina para impedir la adhesion. | |
| ES2159403T3 (es) | Poliuretanos termoplasticos que contienen principios activos. | |
| ES2180514T3 (es) | Uso de un factor con actividad inhibidora del melanoma (mia) para reparacion de cartilagos y huesos. | |
| BR9810693A (pt) | Composição bioativa moldável, composição farmacêutica biocompatìvel, e, processos para reparo, substituição, reconfiguração, reconstrução ou aumento de estruturas anatÈmicas de tecido duro e para induzir osteogênese | |
| ECSP003707A (es) | Diazepanes | |
| ES2195000T3 (es) | Composicion farmaceutica. | |
| PT818973E (pt) | Dispositivo biodegradavel | |
| DE60021350D1 (de) | Mmp-hemmer bei bindegewebserweichung | |
| BR9911885A (pt) | Inibidores da angiogênese | |
| ES2055297T3 (es) | Bogie o carreton universal para vehiculos sobre carriles. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |